IBD Cutting Edge 2025: Where Innovation, Trials, and Multidisciplinary Care Intersect
In partnership with UCSD School of Medicine, Crohn's & Colitis Foundation, and Scripps Research
Join us September 19-21 in Coronado, California!
Join us September 19-21 in Coronado, California!
This CME conference will be taught by nationally known experts who are actively involved in groundbreaking advancements in translational science, drug discovery, and clinical care for inflammatory bowel disease.
About the Conference
About the Conference
Conference Location
Coronado Island Marriott
2000 2nd St
Coronado, California 92118
Discounts available until August 22, 2025
Conference Details
- Exhibitor Prospectus (PDF, 360 KB)
- Maintenance of Certification
- Cultural & Linguistic Competency Resources (PDF, 100 KB)
- Health and Safety Waiver and Assumption of Risk (PDF, 130 KB)
Conference Overview
The IBD Cutting Edge 2025 conference will feature groundbreaking advancements in translational science, drug discovery, and clinical care for inflammatory bowel disease (IBD). The program will emphasize the evolving landscape of clinical trials, innovative therapeutic strategies, and the challenges of managing IBD in diverse patient populations. Key topics include disease-specific complications, care considerations for special populations, the role of surgery in IBD management, and the integration of multidisciplinary approaches to improve treatment outcomes.
The conference will also introduce emerging technologies, patient-centered care initiatives, and discussions on equity in access to care. Attendees will benefit from lectures and interactive sessions led by international and national key opinion leaders in IBD. The comprehensive program will equip healthcare professionals with actionable insights to optimize patient care, advance clinical practices, and improve the quality of life for patients living with IBD.
Educational Objectives
After attending this live activity, participants should be able to:
- Explore Translational Science: Understand how emerging insights from translational research are shaping novel therapeutic approaches for inflammatory bowel disease (IBD).
- Analyze Clinical Trial Innovations: Evaluate findings from recent and ongoing clinical trials to inform the development and application of next-generation therapies for IBD.
- Integrate Multidisciplinary Care Strategies: Identify opportunities to optimize patient outcomes through collaborative care models involving gastroenterologists, surgeons, dietitians, psychologists, and other specialists.
- Implement Advanced Surgical and Medical Approaches: Assess the latest advancements in surgical interventions and medical therapies, including their roles in treating complex IBD cases.
- Address Challenges in Special Populations: Examine the unique treatment considerations for pediatric, adolescent, and high-risk IBD populations, ensuring equitable and personalized care.
- Foster Patient-Centered Care: Develop approaches that emphasize shared decision-making and improved quality of life for patients living with IBD.
Accreditation and Disclosures
Physicians
Scripps Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Nurses and Nurse Practitioners
For the purpose of recertification, the American Nurses Credentialing Center, American Academy of Nurse Practitioners Certified Program (AANPCP) and the American Association of Nurse Practitioners (AANP) accept AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME.
Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.
Pharmacists
The California Board of Pharmacy accepts as continuing professional education those courses that meet the standard of relevance to pharmacy practice and have been approved for AMA PRA Category 1 Credit(s)™.
Commercial Support
This course may be supported, in part, by educational grants from industry. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, a complete list of commercial support received will be provided to all learners who participate in the continuing education activity. For more information: www.accme.org/standards.
Cultural & Linguistic Competency and Implicit Bias
This activity is designed to include curriculum addressing the topics of cultural and linguistic competency (CLC) and implicit bias (IB) in compliance with California Business and Professions (B&P) Code Section 2190. All those involved in the planning and execution of this activity have been asked to identify and discuss issues relevant to the topics being covered. In addition, a variety of resources are available that address cultural and linguistic competency and implicit bias. A resource document can be downloaded from the Conference Details section above.
Maintenance of Certification
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
American Board of Pathology (ABPATH)
Successful completion of this CME activity enables the learner to earn Lifelong Learning (CME) credit toward the CME requirement(s) of the American Board of Pathology’s Continuing Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP credit.
MOC points will be awarded to physicians who successfully complete the requirements outlined in the post-activity evaluation. Points earned will be reported to the appropriate specialty board approximately 60 days post conference as long as all learner requirements are met. These credits will not appear on your CME certificate from Scripps.
Attendance and Cancellation Policies
Attendee Cancellation, Substitution and Refund
The course tuition is refundable, minus a $100 processing fee (MD, DO, RN, PA, NP) or a $50 processing fee (Fellow, Resident, Student), if your cancellation is received in writing no later than Friday, September 5, 2025. Attendee substitutions are allowed, but notification must be made in writing by September 5, 2025. After this date, under no circumstances will refunds, credits, or substitutions be granted. No refunds or credits will be given to “no shows.” No refunds shall be made for cancellations due to inclement weather.
Scripps Conference Modification or Cancellation
Scripps reserves the right to modify the course’s schedule or program as necessary. Scripps also reserves the right to cancel this conference, in which case a full refund of the registration fee will be provided. Attendees who purchase non-refundable airline tickets do so at their own risk. Scripps encourages the purchase of travel insurance as we are unable to refund any travel costs (flight, hotel, etc.) in the case of Scripps cancellation.
Health and Safety Waiver and Assumption of Risk
By completion and submission of the online registration form, attendees certify that they have read and fully understand the Health and Safety Waiver and Assumption of Risk Agreement.
Family and Guest Attendance Policy
All conference activities and meals are exclusively reserved for paid conference attendees. Children and family members are not allowed to attend meal functions or permitted in the meeting space.
Recording and Photography Clause
Scripps reserves exclusive rights to record (audio and video) and/or photograph all conference proceedings for use in marketing materials, presentations and course content sales.
Event details
Sun, Sep 21, 2025 at 3 pm